OVM-200

· Oxford Vacmedix UK Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OVM-200, covering 2025-02-14 to 2025-02-14. Get the full timeline:

Most recent: Clinical Trial Update: First-in-human Study of OVM-200 as a Therapeutic Cancer Vaccine [Phase 1]